• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,100.47 109.25
( 0.14%)
Global Indices
Nasdaq
51,823.54 -118.08
(-0.23%)
Dow Jones
7,358.68 -19.81
(-0.27%)
Hang Seng
69,065.93 -3,300.41
(-4.56%)
Nikkei 225
10,515.14 -14.75
(-0.14%)
Forex
USD-INR
94.41 -0.14
(-0.15%)
EUR-INR
107.28 -0.07
(-0.07%)
GBP-INR
124.48 -0.08
(-0.06%)
JPY-INR
0.58 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Biocon Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532523
INE376G01013
167.0598066
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BIOCON
282.86
67397.35
EPS(TTM)
Face Value()
Div & Yield %
1.47
5
0.12
 

As on: Jun 25, 2026 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
415.80 -5.90 75352 282.86
Stock Price Details
Open Price() 422.45
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 425.40
Today's Low () 414.40
52-Week High () 440.3
152-Week Low () 331
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.12
Eps 1.47
Book Value 167.0598066
Market Cap (.Cr) 67,397.35
Face Value 5
Market Lot 1
AGM Date Aug
Book Closure Date
ISIN No. INE376G01013


News
Biocon secures multiple insulin contracts from Ministry of Health, Malaysia
Biocon's Malaysian partner Duopharma Biotech secures insulin tenders worth over MYR 225 million
Biocon to hold AGM
Biocon Ltd spurts 2.76%, rises for fifth straight session
Biocon Ltd spurts 3.7%, gains for third straight session
Biocon Pharma receives Health Canada approval for micafungin for injection USP 50 mg and 100 mg
Board of Biocon recommends final dividend
Biocon consolidated net profit declines 63.45% in the March 2026 quarter
Biocon posts PAT of Rs 126 crore in Q4 FY26; EBIDTA margin stands at 23%
Biocon Ltd soars 1.16%, gains for fifth straight session
More
Corporate Details
Incoporation Year   : 1978
Chairman : Kiran Mazumdar Shaw
Bussiness Group : Indian Private
Registered Office
Biocon Ltd
20th KM Hosur Road Hebbagodi,
Electronic City P O,
Bangalore,
Karnataka-560100
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-80-28082808
Fax:91-80-28523423
Fax:91-22-66317458
E-Mail : co.secretary@biocon.com
URL : http://www.biocon.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 500
  • BSE 200
  • BSE HC
  • BSE DOLLEX
  • BSE Midcap
  • BSE Shariah 50
  • CNX 500
  • CNX Midcap
  • CNX Pharma
  • CNX 200
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi